Secondary and tertiary structure changes of reconstituted P-glycoprotein.

被引：0
|
作者：
Sonveaux, N
Shapiro, AB
Goormaghtigh, E
Ling, V
Ruysschaert, JM
机构：
[1] FREE UNIV BRUSSELS, CHIM PHYS MACROMOL INTERFACES LAB, B-1050 BRUSSELS, BELGIUM
[2] BRITISH COLUMBIA CANC RES CTR, VANCOUVER, BC V5Z 1L3, CANADA
来源：
BIOPHYSICAL JOURNAL | 1997年 / 72卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：MP322 / MP322
页数：1
相关论文
共 50 条
  • [21] Saquinavir is a high affinity substrate for the multidrug transporter, P-glycoprotein.
    Washington, CB
    Duran, GE
    Sikic, BI
    Blaschke, TF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : OIIA3 - OIIA3
  • [22] Outcome of Helicobacter pylori infection and multidrug resistance P-glycoprotein.
    Nardone, G
    Rocco, A
    Staibano, S
    Balzano, T
    Grazioli, B
    De Rosa, G
    Budillon, G
    GASTROENTEROLOGY, 2000, 118 (04) : A499 - A499
  • [23] Multidrug resistance protein MRP1 reconstituted into lipid vesicles: Secondary structure and nucleotide-induced tertiary structure changes
    Manciu, L
    Chang, XB
    Riordan, JR
    Ruysschaert, JM
    BIOCHEMISTRY, 2000, 39 (42) : 13026 - 13033
  • [24] Secondary and tertiary structure changes of reconstituted multidrug resistance protein (MRP1) induced by nucleotide and drug binding
    Manciu, L
    Chang, XB
    Riordan, JR
    Ruysschaert, JM
    BIOPHYSICAL JOURNAL, 2002, 82 (01) : 525A - 525A
  • [25] Multiple site interaction of triazolam and ketoconazole in mice: Role of P-glycoprotein.
    von Moltke, LL
    Granda, BW
    Grassi, JM
    Greenblatt, DJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 143 - 143
  • [26] Intracellular xenobiotic concentration as a key factor of cytotoxicity: role of P-glycoprotein.
    Simonova V.S.
    Samusenko A.V.
    Polosukhina E.R.
    Baryshnikov A.Y.
    Shtil A.A.
    Doklady Biological Sciences, 2004, 394 (1-6) : 90 - 93
  • [27] Interactions of tamoxifen and metabolites with human CYP3A and P-glycoprotein.
    Bekaii-Saab, T
    Perloff, M
    Weemhoff, J
    von Moltke, L
    Greenblatt, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P11 - P11
  • [28] Enhanced distribution of nelfinavir into brain and testes by pharmacologic inhibition of P-glycoprotein.
    Choo, EF
    Wood, AJJ
    Wilkinson, GR
    Kim, RB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 114 - 114
  • [29] Binding of modulators to mouse and human multidrug resistance P-glycoprotein. A computational study
    Jara, Gabriel E.
    Vera, D. Mariano A.
    Pierini, Adriana B.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2013, 46 : 10 - 21
  • [30] Descriptors based on similarity measures for qsar-studies of inhibitors of p-glycoprotein.
    Ecker, GF
    Chiba, P
    Klein, C
    Kaiser, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U404 - U404
12345